Ledger.Open graph →
SEC Form D · filed August 6, 2015

VistaGen Therapeutics, Inc

Offering
$10.0M
Sold
$1.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
South San Francisco, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Shawn K. Singh · South San Francisco, CAExec · DirectorAsia Capital Management, L.P · Grand Cayman, Cayman IslandsExec · DirectorMark W. Brooker · Houston, TXDirectorUnderdown J. Brian · South San Francisco, CADirectorPaul G. Roess · Chattanooga, TNExec · DirectorJerrold D. Dotson · South San Francisco, CAExecIshaan Nerurkar · Berkeley, CADirectorMark Rose · Chicago, ILExec · DirectorColton Jang · Berkeley, CAExecJon S. Saxe · South San Francisco, CADirectorH. R. Snodgrass · South San Francisco, CAExec · DirectorUnderdown J. Brian · South San Francisco, CADirectorEarl Webb · Chicago, ILExecMichael Theilmann · Berkeley, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗